Profile | GDS5420 / 215075_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 382.56 | 63 |
GSM1296119 | B_lesional_pre-dose | 351.58 | 62 |
GSM1296076 | C_lesional_pre-dose | 218.65 | 55 |
GSM1296092 | D_lesional_pre-dose | 277.88 | 59 |
GSM1296103 | E_lesional_pre-dose | 424.84 | 65 |
GSM1296078 | F_lesional_pre-dose | 229.03 | 56 |
GSM1296107 | G_lesional_pre-dose | 451.72 | 66 |
GSM1296109 | H_lesional_pre-dose | 620.81 | 71 |
GSM1296080 | I_lesional_pre-dose | 365.92 | 63 |
GSM1296090 | J_lesional_pre-dose | 255.8 | 57 |
GSM1296074 | K_lesional_pre-dose | 302.34 | 61 |
GSM1296111 | L_lesional_pre-dose | 420.9 | 65 |
GSM1296099 | M_lesional_pre-dose | 304.53 | 59 |
GSM1296086 | O_lesional_pre-dose | 295.14 | 60 |
GSM1296117 | P_lesional_pre-dose | 431.48 | 65 |
GSM1296113 | Q_lesional_pre-dose | 436.29 | 65 |
GSM1296096 | R_lesional_pre-dose | 372.3 | 63 |
GSM1296105 | S_lesional_pre-dose | 308.55 | 59 |
GSM1296098 | T_lesional_pre-dose | 367.49 | 62 |
GSM1296101 | U_lesional_pre-dose | 303.16 | 59 |
GSM1296121 | V_lesional_pre-dose | 476.78 | 67 |
GSM1296088 | W_lesional_pre-dose | 303.24 | 60 |
GSM1296082 | X_lesional_pre-dose | 310.79 | 61 |
GSM1296115 | Y_lesional_pre-dose | 502.19 | 68 |
GSM1296084 | Z_lesional_pre-dose | 217.89 | 54 |
GSM1296072 | B_lesional_day8 | 280.65 | 57 |
GSM1296069 | L_lesional_day8 | 551.6 | 69 |
GSM1296071 | P_lesional_day8 | 372.01 | 62 |
GSM1296070 | Y_lesional_day8 | 352.39 | 61 |
GSM1296073 | V_lesional_day8 | 337.42 | 62 |
GSM1296034 | A_lesional_day15 | 262.65 | 56 |
GSM1296041 | G_lesional_day15 | 430.88 | 65 |
GSM1296035 | R_lesional_day15 | 354.44 | 62 |
GSM1296038 | U_lesional_day15 | 285.64 | 58 |
GSM1296047 | B_lesional_day15 | 259.24 | 56 |
GSM1296039 | E_lesional_day15 | 312.87 | 60 |
GSM1296042 | H_lesional_day15 | 336.19 | 61 |
GSM1296043 | L_lesional_day15 | 393.93 | 63 |
GSM1296037 | M_lesional_day15 | 232.01 | 54 |
GSM1296046 | P_lesional_day15 | 347.73 | 61 |
GSM1296044 | Q_lesional_day15 | 313.38 | 59 |
GSM1296045 | Y_lesional_day15 | 361.99 | 61 |
GSM1296025 | C_lesional_day15 | 223.49 | 55 |
GSM1296033 | D_lesional_day15 | 335.74 | 61 |
GSM1296027 | I_lesional_day15 | 127.22 | 47 |
GSM1296032 | J_lesional_day15 | 175.18 | 50 |
GSM1296024 | K_lesional_day15 | 262.59 | 57 |
GSM1296031 | W_lesional_day15 | 230.28 | 54 |
GSM1296028 | X_lesional_day15 | 190.59 | 52 |
GSM1296029 | Z_lesional_day15 | 177.65 | 51 |
GSM1296026 | F_lesional_day15 | 290.53 | 59 |
GSM1296030 | O_lesional_day15 | 257.89 | 58 |
GSM1296040 | S_lesional_day15 | 307.31 | 59 |
GSM1296036 | T_lesional_day15 | 294.69 | 58 |
GSM1296048 | V_lesional_day15 | 325.78 | 60 |
GSM1296059 | A_lesional_day43 | 317.41 | 60 |
GSM1296066 | G_lesional_day43 | 360.83 | 62 |
GSM1296060 | R_lesional_day43 | 276.9 | 57 |
GSM1296063 | U_lesional_day43 | 252.48 | 56 |
GSM1296064 | E_lesional_day43 | 361.59 | 63 |
GSM1296067 | H_lesional_day43 | 303.71 | 58 |
GSM1296062 | M_lesional_day43 | 263.14 | 56 |
GSM1296068 | Q_lesional_day43 | 402.31 | 63 |
GSM1296050 | C_lesional_day43 | 158.88 | 49 |
GSM1296057 | D_lesional_day43 | 263.68 | 57 |
GSM1296052 | I_lesional_day43 | 143 | 48 |
GSM1296054 | J_lesional_day43 | 176.67 | 50 |
GSM1296049 | K_lesional_day43 | 159.81 | 49 |
GSM1296055 | W_lesional_day43 | 291.11 | 58 |
GSM1296053 | X_lesional_day43 | 195.12 | 52 |
GSM1296058 | Z_lesional_day43 | 223.73 | 55 |
GSM1296051 | F_lesional_day43 | 231.23 | 56 |
GSM1296056 | O_lesional_day43 | 346.34 | 62 |
GSM1296065 | S_lesional_day43 | 256.42 | 56 |
GSM1296061 | T_lesional_day43 | 359.23 | 61 |
GSM1296095 | A_non-lesional_pre-dose | 250.46 | 56 |
GSM1296120 | B_non-lesional_pre-dose | 276.98 | 57 |
GSM1296077 | C_non-lesional_pre-dose | 228.23 | 55 |
GSM1296093 | D_non-lesional_pre-dose | 179.23 | 50 |
GSM1296104 | E_non-lesional_pre-dose | 276.45 | 58 |
GSM1296079 | F_non-lesional_pre-dose | 162.09 | 50 |
GSM1296108 | G_non-lesional_pre-dose | 314.79 | 59 |
GSM1296110 | H_non-lesional_pre-dose | 400.41 | 63 |
GSM1296081 | I_non-lesional_pre-dose | 200.56 | 54 |
GSM1296091 | J_non-lesional_pre-dose | 172.4 | 51 |
GSM1296075 | K_non-lesional_pre-dose | 199.36 | 54 |
GSM1296112 | L_non-lesional_pre-dose | 372.66 | 62 |
GSM1296100 | M_non-lesional_pre-dose | 272.49 | 57 |
GSM1296087 | O_non-lesional_pre-dose | 209.07 | 55 |
GSM1296118 | P_non-lesional_pre-dose | 359.43 | 61 |
GSM1296114 | Q_non-lesional_pre-dose | 393.35 | 63 |
GSM1296097 | R_non-lesional_pre-dose | 219.22 | 54 |
GSM1296106 | S_non-lesional_pre-dose | 252.62 | 55 |
GSM1296102 | U_non-lesional_pre-dose | 209.63 | 52 |
GSM1296122 | V_non-lesional_pre-dose | 287.98 | 58 |
GSM1296089 | W_non-lesional_pre-dose | 203.63 | 52 |
GSM1296083 | X_non-lesional_pre-dose | 230.92 | 55 |
GSM1296116 | Y_non-lesional_pre-dose | 386.43 | 62 |
GSM1296085 | Z_non-lesional_pre-dose | 194.57 | 52 |